Approval · Notice of Compliance 10137 · 2009
MELOXICAM: Notice of Compliance 10137
Issued April 8, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10137
- Date
- April 8, 2009
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Non-steroidal anti-inflammatory drug (nsaid)
- Canadian reference product
- MOBICOX (Boehringer Ingelheim (Canada) Ltd.)